Mabudian, Leila
Reding, Kerry
D’Agostino, Ralph B. Jr
Heiston, Emily M.
Bellissimo, Moriah P.
Olson, Kristine
Ntim, William O.
Klepin, Heidi D.
Dressler, Emily V.
Moore, Tonya
Jordan, Jennifer H.
O’Connell, Nathaniel S.
Ladd, Amy
Weaver, Kathryn E.
Ky, Bonnie
Wagner, Lynne I.
Hackney, Mary Helen
Lesser, Glenn J.
Hundley, W Gregory
,
Funding for this research was provided by:
NIH (UG1CA189824, UG1CA189828, UG1CA189824, R01CA167821, R01CA199167)
Article History
Received: 20 December 2023
Accepted: 1 May 2024
First Online: 6 June 2024
Declarations
:
: This prospective cohort study (NIH R01CA167821 & R01CA199167) was conducted in collaboration with the Wake Forest National Cancer Institute Community Oncology Research Program Research Base and ECOG-ACRIN Cancer Research Group under a National Cancer Institute CIRB-approved protocol and a Wake Forest University School of Medicine (WFU SOM UG1CA189824, ECOG-ACRIN UG1CA189828) IRB approved protocol. All participants provided written informed consent.
: Not applicable.
: The authors declare no competing interests.